Rheolytic thrombectomy (angiojet) in the treatment of acute thrombosis
Concerns relate to pharmaceutical agent - The risks and benefits of the procedure are sufficiently well known and the concerns over the safety and efficacy of the procedure are related solely to the use of a pharmacological agent/ medical device rather than to the procedure itself.
To fall within the Programme's remit, a notified procedure must involve an incision or a puncture or entry into a body cavity, or the use of ionising, electromagnetic or acoustic energy.
This page was last updated: 30 March 2010
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.